NCT06649162招募中不适用
A Multi-center, Prospective, Cohort Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10,000
- 试验地点
- 2
- 主要终点
- Percentage of subjects who correspond to high risk score (≥8) by evaluating simple NAFLD score
研究概览
简要总结
The purpose of this study is to identify the risk of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes in clinical practice and to evaluate the clinical usefulness of Dapagliflozin/Pioglitazone combination therapy
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Among patients with type 2 diabetes, those who are scheduled to administer a fixed-dose combination of dapagliflozin/pioglitazone at baseline (visit 1)
- •Those who voluntarily signed a written personal information collection and usage agreement after listening to an explanation about the objective and method, etc. of this clinical study.
排除标准
- •Those who have a history of taking a fixed-dose combination of dapagliflozin/pioglitazone at baseline (visit 1).
- •Those who are expected to need insulin prescription during the study period.
结局指标
主要结局
Percentage of subjects who correspond to high risk score (≥8) by evaluating simple NAFLD score
时间窗: Baseline (visit 1)
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
Liver Fibrosis in Peri-menopausal WomenNonalcoholic SteatohepatitisLiver FibrosesMenopauseNCT03602573Chang Gung Memorial Hospital200
尚未招募
不适用
Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in ChineseNonalcoholic Fatty LiverNonalcoholic SteatohepatitisNCT03282305Great China Fatty Liver Consortium Limited5,000
Unknown
不适用
Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.NASH - Nonalcoholic SteatohepatitisNCT04653311Erasme University Hospital100
进行中（未招募）
不适用
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, LiverCirrhosis, LiverType 1 DiabetesNCT04595474Joslin Diabetes Center533
招募中
不适用
Establishment of NAFLD Cohort and Development of Fibrosis MarkersFibrosis of LiverNCT02206841Seoul National University Boramae Hospital1,000